SCHEMBL19979809

SCHEMBL19979809

C=CCOC(O)N1CCC[C@@H]1c1nc(CNC(=O)OC(C)(C)C)no1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.38
GFER P55789 1/20 0.34
CYP2D6 P10635 4/20 0.34
ROCK2 O75116 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
EPHA2 P29317 1/20 0.31
KDR P35968 1/20 0.31
EPHB4 P54760 1/20 0.31
ALDH1A1 P00352 2/20 0.31
TSHR P16473 1/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
IRAK1 P51617 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
ACACB O00763 1/20 0.30
CHRM1 P11229 1/20 0.30
SMO Q99835 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19979716 0.82 ALDH1A1 (0.39) CYP1A2CYP2D6L3MBTL1EPHA2KDR
SCHEMBL19979715 0.82 ALDH1A1 (0.39) CYP1A2CYP2D6L3MBTL1EPHA2KDR
SCHEMBL19979742 0.73 CYP3A4 (0.39) L3MBTL1EPHA2KDREPHB4ALDH1A1
SCHEMBL19979749 0.73 CYP3A4 (0.39) L3MBTL1EPHA2KDREPHB4ALDH1A1
SCHEMBL29176525 0.72 CYP1A2 (0.38) CYP1A2GFERCYP2D6L3MBTL1EPHA2
SCHEMBL29176527 0.72 CYP1A2 (0.38) CYP1A2GFERCYP2D6L3MBTL1EPHA2
SCHEMBL29176594 0.68 CYP1A2 (0.44) CYP1A2GFERCYP2D6L3MBTL1EPHA2
SCHEMBL29176596 0.68 CYP1A2 (0.44) CYP1A2GFERCYP2D6L3MBTL1EPHA2
SCHEMBL19975457 0.68 MAOA (0.39) L3MBTL1EPHA2KDREPHB4ALDH1A1
SCHEMBL30147129 0.68 CYP1A2 (0.41) CYP1A2CYP2D6L3MBTL1EPHA2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018053302-A1 MACROCYCLIC COMPOUNDS FOR THE INHIBITION OF INDOLEAMINE-2,3-DIOXYGENASE ACTIVITY AND USE THEREOF ENSEMBLE THERAPEUTICS CORPORATION (US) 2018-03-22 WO disclosed